News & Updates

Catheter-directed thrombolysis (CDT) is superior to systemic anticoagulation (SA) for the treatment of submassive pulmonary embolism (sPE), leading to better mortality rates without additional safety signals, a recent meta-analysis has found.

Treatment with empagliflozin results in a reduction in heart failure (HF) risk and renal outcomes and in better health-related quality of life (HRQoL) among patients with chronic HF with preserved ejection fraction (HFpEF), a study has shown. In addition, the study drug is well tolerated by older patients.

One out of five severe COVID-19 survivors who underwent mechanical ventilation have coronary artery disease (CAD), a quarter have subclinical left ventricular dysfunction defined as reduced echocardiographic global longitudinal strain (GLS), and 42 percent have cardiac magnetic resonance (CMR) abnormalities, reports a study.

The seventh survey using data from the Tromsø Study (Tromsø7) revealed an association between coffee consumption and increased serum total cholesterol (S-TC) levels among adults and the elderly, with brewing method influencing this association.

Systemic thromboxane generation appears to increase the risk of all-cause and cardiovascular mortality regardless of aspirin use, reveals a study. Hence, its measurement may help inform therapy modification, especially in individuals without cardiovascular disease (CVD).